A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)
Clinical trial NCT05343455 · COMPLETED
Trial details
- NCT number
- NCT05343455
- Sponsor
- Journey Medical Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-29
- Primary completion
- 2023-06-30
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.